
Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
Description
About Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
The Respiratory Syncytial Virus (RSV) A (strain S-2) Nucleoprotein Peptide (IEDB: 32357) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-KMLKEMGEV-OH (Uniprot: O12395 aa: 137-145) from JPT is produced under strict quality control and quality management.
Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV - Specifications
- Peptide sequence: H-KMLKEMGEV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
References:
Read References with JPT’s Antigen Peptides
Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV has been described in:
Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes., Viral Immunol, 2007 (PMID: 17931110)
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing., PLoS One, 2015 (PMID: 26509579)
The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles., Genes Immun, 2011 (PMID: 21654843)
Documentation
Documentation for Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
Properties
Properties of Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Respiratory Syncytial Virus (RSV) |
Protein Name: | Nucleoprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human RSV A (strain S-2) Nucleoprotein 137-145, KMLKEMGEV
Information | Values |
---|---|
Sequence: | H-KMLKEMGEV-OH |
Specifications: | 9mer peptide as TFA salt |